Cardiac-targeted delivery of a novel Drp1 inhibitor for acute cardioprotection

This work was supported by the Heart Foundation Vanguard Grant (104710 to S.Y.L., 105072 to D.W.G.), St Vincent’s Hospital (Melbourne) Research Endowment Fund and Stafford Fox Medical Research Foundation. D.H. is supported by the Duke-NUS Signature Research Programme funded by the Ministry of Health, Singapore Ministry of Health’s National Medical Research Council under its Singapore Translational Research Investigator Award (MOH-STaR21jun-0003), Centre Grant scheme (NMRC CG21APR1006), and Collaborative Centre Grant scheme (NMRC/CG21APRC006). The St Vincent’s Institute of Medical Research and Baker Heart & Diabetes Institute receive Operational Infrastructure Support from the Victorian State Government’s Department of Innovation, Industry and Regional Development.